pharma · Fatty Liver · Inflammatory Disease · GLMD
Galmed Pharmaceuticals
Galmed Pharmaceuticals is a pharma organization headquartered in Tel Aviv, USA. It trades on NYSE under ticker GLMD. Primary therapeutic focus areas include Fatty Liver, Inflammatory Disease, Nonalcoholic Steatohepatitis
16 Ze’ev Tiomkin Street, Tel Aviv, 6578317, IL, USA HQ
2000 Founded
10 Employees
Public company Type
GLMD · NYSE Ticker
Company details
- Status
- Public
- HQ
- 16 Ze’ev Tiomkin Street, Tel Aviv, 6578317, IL, USA
- Founded
- 2000
- Employees
- 10
- Programs
- 13
- Drugs
- 5
- Patents
- 11
Aramchol meglumine
Phase 2 · small molecule · Primary Sclerosing Cholangitis
Aramchol meglumine for Primary Sclerosing Cholangitis is a Phase 2 program (small_molecule) at Galmed Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Internal code AM-002
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Galmed Pharmaceuticals
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Primary Sclerosing Cholangitis
- Status
- terminated
- Trials
- 1